% Generated by roxygen2: do not edit by hand
% Please edit documentation in R/serocalculator-package.R
\name{serocalculator}
\alias{serocalculator}
\alias{serocalculator-package}
\title{Estimating Infection Rates from Serological Data}
\description{
This package translates antibody levels measured in a (cross-sectional) population sample into an
estimate of the frequency with which seroconversions (infections) occur in the sampled population.

The API for this package includes the following functions:\tabular{ll}{
   Function Name \tab Purpose \cr
   \code{\link[=load_pop_data]{load_pop_data()}} \tab loading cross-sectional antibody survey data \cr
   \code{\link[=clean_pop_data]{clean_pop_data()}} \tab cleaning antibody data \cr
   \code{\link[=check_pop_data]{check_pop_data()}} \tab checking antibody data \cr
   \code{\link[=summary.pop_data]{summary.pop_data()}} \tab numerical summaries of antibody data \cr
   \code{\link[=autoplot.pop_data]{autoplot.pop_data()}} \tab graphs of antibody data distributions \cr
   \code{\link[=load_curve_params]{load_curve_params()}} \tab loading antibody decay curve models \cr
   \code{\link[=autoplot.curve_params]{autoplot.curve_params()}} \tab graphing antibody decay curves \cr
   \code{\link[=log_likelihood]{log_likelihood()}} \tab computing log-likelihoods \cr
   \code{\link[=graph.loglik]{graph.loglik()}} \tab graphing log-likelihood functions \cr
   \code{\link[=autoplot.seroincidence]{autoplot.seroincidence()}} \tab graphing log-likelihood functions \cr
   \code{\link[=autoplot.seroincidence.by]{autoplot.seroincidence.by()}} \tab graphing log-likelihood functions \cr
   \code{\link[=est.incidence]{est.incidence()}} \tab estimating incidence rates \cr
   \code{\link[=est.incidence.by]{est.incidence.by()}} \tab estimating incidence rates by strata \cr
   \code{\link[=summary.seroincidence.by]{summary.seroincidence.by()}} \tab summarizing stratified incidence rate estimates \cr
   \code{\link[=autoplot.summary.seroincidence.by]{autoplot.summary.seroincidence.by()}} \tab graphing incidence rate estimates \cr
   \code{\link[=sim.cs]{sim.cs()}} \tab simulating cross-sectional population antibody data using longitudinal seroresponse models \cr
}
}
\details{
_PACKAGE
}
\references{
\emph{\strong{Methods for estimating seroincidence}}
\itemize{
\item Teunis, P. F. M., and J. C. H. van Eijkeren. "Estimation of seroconversion rates for infectious diseases: Effects of age and noise." Statistics in Medicine 39, no. 21 (2020): 2799-2814.
\item Teunis, P. F. M., J. C. H. van Eijkeren, W. F. de Graaf, A. Bonačić Marinović, and M. E. E. Kretzschmar. "Linking the seroresponse to infection to within-host heterogeneity in antibody production." Epidemics 16 (2016): 33-39.
}

\emph{\strong{Applications}}
\itemize{
\item Aiemjoy, Kristen, Jessica C. Seidman, Senjuti Saha, Sira Jam Munira, Mohammad Saiful Islam Sajib, Syed Muktadir Al Sium, Anik Sarkar et al. "Estimating typhoid incidence from community-based serosurveys: a multicohort study." The Lancet Microbe 3, no. 8 (2022): e578-e587.
\item Aiemjoy, Kristen, John Rumunu, Juma John Hassen, Kirsten E. Wiens, Denise Garrett, Polina Kamenskaya, Jason B. Harris et al. "Seroincidence of enteric fever, Juba, South Sudan." Emerging infectious diseases 28, no. 11 (2022): 2316.
\item Monge, S., Teunis, P. F., Friesema, I., Franz, E., Ang, W., van Pelt, W., Mughini-Gras, L.
"Immune response-eliciting exposure to Campylobacter vastly exceeds the incidence of clinically
overt campylobacteriosis but is associated with similar risk factors: A nationwide serosurvey in the Netherlands"
Journal of Infection, 2018, 1--7, doi:10.1016/j.jinf.2018.04.016
\item Kretzschmar, M., Teunis, P. F., Pebody, R. G.
"Incidence and reproduction numbers of pertussis: estimates from serological and social contact data in five European countries"
PLoS Medicine 7, no. 6 (June 1, 2010):e1000291. doi:10.1371/journal.pmed.1000291.
\item Simonsen, J., Strid, M. A., Molbak, K., Krogfelt, K. A., Linneberg, A., Teunis, P.
"Sero-epidemiology as a tool to study the incidence of Salmonella infections in humans"
Epidemiology and Infection 136, no. 7 (July 1, 2008): 895--902. doi:10.1017/S0950268807009314
\item Simonsen, J., Teunis, P. F., van Pelt, W., van Duynhoven, Y., Krogfelt, K. A., Sadkowska-Todys, M., Molbak K.
"Usefulness of seroconversion rates for comparing infection pressures between countries"
Epidemiology and Infection, April 12, 2010, 1--8. doi:10.1017/S0950268810000750.
\item Falkenhorst, G., Simonsen, J., Ceper, T. H., van Pelt, W., de Valk, H., Sadkowska-Todys, M., Zota, L., Kuusi, M., Jernberg, C., Rota, M. C., van Duynhoven, Y. T., Teunis, P. F., Krogfelt, K. A., Molbak, K.
"Serological cross-sectional studies on salmonella incidence in eight European countries: no correlation with incidence of reported cases"
BMC Public Health 12, no. 1 (July 15, 2012): 523--23. doi:10.1186/1471-2458-12-523.
\item Teunis, P. F., Falkenhorst, G., Ang, C. W., Strid, M. A., De Valk, H., Sadkowska-Todys, M., Zota, L., Kuusi, M., Rota, M. C., Simonsen, J. B., Molbak, K., Van Duynhoven, Y. T., van Pelt, W.
"Campylobacter seroconversion rates in selected countries in the European Union"
Epidemiology and Infection 141, no. 10 (2013): 2051--57. doi:10.1017/S0950268812002774.
\item de Melker, H. E., Versteegh, F. G., Schellekens, J. F., Teunis, P. F., Kretzschmar, M.
"The incidence of Bordetella pertussis infections estimated in the population from a combination of serological surveys"
The Journal of Infection 53, no. 2 (August 1, 2006): 106--13. doi:10.1016/j.jinf.2005.10.020
}

\emph{\strong{Quantification of seroresponse}}
\itemize{
\item de Graaf, W. F., Kretzschmar, M. E., Teunis, P. F., Diekmann, O.
"A two-phase within-host model for immune response and its application to serological profiles of pertussis"
Epidemics 9 (2014):1--7. doi:10.1016/j.epidem.2014.08.002.
\item Berbers, G. A., van de Wetering, M. S., van Gageldonk, P. G., Schellekens, J. F., Versteegh, F. G., Teunis, P.F.
"A novel method for evaluating natural and vaccine induced serological responses to Bordetella pertussis antigens"
Vaccine 31, no. 36 (August 12, 2013): 3732--38. doi:10.1016/j.vaccine.2013.05.073.
\item Versteegh, F. G., Mertens, P. L., de Melker, H. E., Roord, J. J., Schellekens, J. F., Teunis, P. F.
"Age-specific long-term course of IgG antibodies to pertussis toxin after symptomatic infection with Bordetella pertussis"
Epidemiology and Infection 133, no. 4 (August 1, 2005): 737--48.
\item Teunis, P. F., van der Heijden, O. G., de Melker, H. E., Schellekens, J. F., Versteegh, F. G., Kretzschmar, M. E.
"Kinetics of the IgG antibody response to pertussis toxin after infection with B. pertussis"
Epidemiology and Infection 129, no. 3 (December 10, 2002):479. doi:10.1017/S0950268802007896.
}
}
\author{
\itemize{
\item Peter Teunis \email{p.teunis@emory.edu}
\item Doug Ezra Morrison \email{demorrison@ucdavis.edu}
\item Kristen Aiemjoy \email{kaiemjoy@ucdavis.edu}
\item Kristina Lai \email{kwlai@ucdavis.edu}
}
}
